Holdings derived from the most recent reported transactions. Not adjusted for stock splits or share-class conversions.
| Issuer | Shares | Source | Last tx | Detail |
|---|---|---|---|---|
| DURECT CORP | 50,000 | reported | 27 Feb 2004 | tx 1+50,000 |
| SURMODICS INC | 6,176 | reported | 03 Dec 2014 | tx 4+10,863 |
| MAP Pharmaceuticals, Inc. | 0 | reported | 01 Mar 2013 | tx 60+1,076,061−1,976,553 |
| IMPEL NEUROPHARMA INC | 0 | reported | 05 Apr 2024 | tx 11+47,511−85,192 |
| Date | Type | Issuer | Qty | Price | Signals |
|---|---|---|---|---|---|
| 05 Apr 2024 | OTHER | IMPEL NEUROPHARMA INC | 10,000 | 0.00 USD | |
| 05 Apr 2024 | OTHER | IMPEL NEUROPHARMA INC | 12,303 | 0.00 USD | deriv |
| 05 Apr 2024 | OTHER | IMPEL NEUROPHARMA INC | 12,789 | 0.00 USD | deriv |
| 05 Apr 2024 | OTHER | IMPEL NEUROPHARMA INC | 13,222 | 0.00 USD | deriv |
| 05 Apr 2024 | OTHER | IMPEL NEUROPHARMA INC | 22,325 | 0.00 USD | deriv |
| 05 Apr 2024 | OTHER | IMPEL NEUROPHARMA INC | 3,053 | 0.00 USD | deriv |
| 05 Apr 2024 | OTHER | IMPEL NEUROPHARMA INC | 11,500 | 0.00 USD | deriv |
| 16 Jun 2023 | GRANT_AWARD | IMPEL NEUROPHARMA INC | 13,222 | 0.00 USD | deriv |
| 16 Jun 2022 | GRANT_AWARD | IMPEL NEUROPHARMA INC | 12,789 | 0.00 USD | deriv |
| 19 Nov 2021 | PURCHASE | IMPEL NEUROPHARMA INC | 10,000 | 10.76 USD | first after silence |
| 11 Jul 2021 | GRANT_AWARD | IMPEL NEUROPHARMA INC | 11,500 | 0.00 USD | deriv |
| 03 Dec 2014 | GRANT_AWARD | SURMODICS INC | 1,118 | 0.00 USD | |
| 03 Dec 2014 | GRANT_AWARD | SURMODICS INC | 4,430 | 0.00 USD | deriv |
| 17 Feb 2014 | GRANT_AWARD | SURMODICS INC | 1,217 | 0.00 USD | |
| 17 Feb 2014 | GRANT_AWARD | SURMODICS INC | 4,098 | 0.00 USD | deriv |
| 01 Mar 2013 | TENDER | MAP Pharmaceuticals, Inc. | 38,740 | 25.00 USD | |
| 01 Mar 2013 | OTHER | MAP Pharmaceuticals, Inc. | 121,468 | 0.00 USD | deriv |
| 01 Mar 2013 | OTHER | MAP Pharmaceuticals, Inc. | 180,790 | 0.00 USD | deriv |
| 01 Mar 2013 | OTHER | MAP Pharmaceuticals, Inc. | 160,000 | 0.00 USD | deriv |
| 01 Mar 2013 | OTHER | MAP Pharmaceuticals, Inc. | 175,000 | 0.00 USD | deriv |
| 01 Mar 2013 | OTHER | MAP Pharmaceuticals, Inc. | 100,000 | 0.00 USD | deriv |
| 01 Mar 2013 | OTHER | MAP Pharmaceuticals, Inc. | 179,176 | 0.00 USD | deriv |
| 01 Mar 2013 | OTHER | MAP Pharmaceuticals, Inc. | 112,500 | 0.00 USD | deriv |
| 01 Mar 2013 | OTHER | MAP Pharmaceuticals, Inc. | 28,125 | 0.00 USD | deriv |
| 01 Mar 2013 | OTHER | MAP Pharmaceuticals, Inc. | 132,549 | 0.00 USD | deriv |
1 purchase reported after at least 12 months of silence — most recent on 19 Nov 2021.